Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Case Reports
. 2024 Dec 19:14:1408506.
doi: 10.3389/fonc.2024.1408506. eCollection 2024.

Case report: Anesthesia management for surgical treatment of glucagonoma with symptom of characterized necrolytic migratory erythema

Affiliations
Case Reports

Case report: Anesthesia management for surgical treatment of glucagonoma with symptom of characterized necrolytic migratory erythema

Di Xia et al. Front Oncol. .

Abstract

Background: The anesthetic management of patients with glucagonoma is complicated by a number of factors including glucose fluctuation, characterized necrolytic migratory erythema in oral and pharyngeal, which may lead to an unexpected difficult airway.

Case presentation: Herein we describe the anesthetic considerations and management of a 47-year-old adult with glucagonoma, who presented for a laparoscopic splenectomy and distal pancreatectomy procedure.

Conclusion: This report details fiberoptic intubation in an adult with glucagonoma and necrolytic migratory erythema. We recommend that this approach be considered in patients with glucagonoma and severe necrolytic migratory erythema undergoing general anesthesia.

Keywords: anesthesia management; difficult airway; fiberoptic intubation; glucagonoma; necrolytic migratory erythema.

PubMed Disclaimer

Conflict of interest statement

The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.

Figures

Figure 1
Figure 1
Cutaneous manifestations of necrolytic migratory erythema. Necrolytic migratory erythema distributed on the patient’s face (A), hands (B), elbows (C), and sacrum (D). Figure E shows glossitis, stomatitis, or cheilitis.
Figure 2
Figure 2
The CT scan of glucagonoma (The red arrow shows the location of the tumor. The two images show the arterial phase of the enhanced CT scan and the portal phase of the enhanced CT scan.)
Figure 3
Figure 3
Oropharyngeal cavity under fiberscope. (A) shows the narrow pharynx; (B) shows glottis under fiberoptic bronchoscope; (C) shows the carina; (D) shows a tracheal catheter placed in the appropriate position within the airway.
Figure 4
Figure 4
Pancreatic glucagonoma tumor body (A); Histological examination of the mass showing an (B) (Hematoxylin and Eosin (H&E) staining of tissue section, showing well-defined alpha-cell pancreatic tumor cellular architecture).

Similar articles

References

    1. Batcher E, Madaj P, Gianoukakis AG. Pancreatic neuroendocrine tumors. Endocr Res. (2011) 36:35–43. doi: 10.3109/07435800.2010.525085 - DOI - PubMed
    1. Li W, Yang X, Deng Y, Jiang Y, Xu G, Li E, et al. . Dong S et al: Necrolytic migratory erythema is an important visual cutaneous clue of glucagonoma. Sci Rep. (2022) 12:9053. doi: 10.1038/s41598-022-12882-2 - DOI - PMC - PubMed
    1. Song X, Zheng S, Yang G, Xiong G, Cao Z, Feng M, et al. . Glucagonoma and the glucagonoma syndrome. Oncol Lett. (2018) 15:2749–55. doi: 10.3892/ol.2017.7703 - DOI - PMC - PubMed
    1. Phan GQ, Yeo CJ, Hruban RH, Lillemoe KD, Pitt HA, Cameron JL. Surgical experience with pancreatic and peripancreatic neuroendocrine tumors: review of 125 patients. J Gastrointest Surg. (1998) 2:472–82. doi: 10.1016/S1091-255X(98)80039-5 - DOI - PubMed
    1. Makis W, McCann K, Riauka TA, McEwan AJ. Glucagonoma pancreatic neuroendocrine tumor treated with 177Lu DOTATATE induction and maintenance peptide receptor radionuclide therapy. Clin Nucl Med. (2015) 40:877–9. doi: 10.1097/RLU.0000000000000891 - DOI - PubMed

Publication types

LinkOut - more resources